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ABSTRACT   
Precise characterization of clinical phenotypes and revelation of genetic markers for the predisposing to have renal 
maladies or alter its course has been bothersome and exhausting. However, some genetic variants have been linked to 
kidney disorders. Methods: This study involved 120 subjects (70 hemodialysis-treated patients with chronic renal 
failure and 50 healthy subjects as control). Serum biochemical parameters creatinine and urea were detected as 
diagnostic markers to renal functions. Sixty subjects (44 patients & 16 control) were genotyped for polymorphism of 
the enzyme gene conversion of angiotensin. The distribution of genotype and allele frequencies for angiotensin-
converting enzyme - Deletion / Insertion single nucleotide polymorphisms has been evaluated in both groups. Results 
: The levels of biochemical parameters creatinine, and urea in renal failure patients increased significantly when 
compared with healthy .The angiotensin-converting enzyme genotypes distribution between subjects groups in Thi-
Qar indicated that the percentage of DD genotype was found to be high in the group of 23 patients (52.3%), followed 
by ID 16 (36.3%) and II genotype 5 (11.4%).  As, the genetic pattern in the control group showed that the genotype 
DD and ID patterns had the same percentage of 37.3%, followed by genotype II, 25% . Also, there is an increase of D-
allele frequencies in the group of patients equivalent with healthy controls. Conclusions: The high frequency of 
angiotensin-converting enzyme DD genotype and D allele compared to control in chronic renal failure patients can be 
a significant factor in the development of renal failure. 
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1.1. Introduction 
 Genetic factor plays an important role in chronic kidney disease progression and end-stage kidney 
disease (ESRD) development [1]. As noted, the rate of long-term renal function loss presents a great contrast 
between individuals, even among those who have the same type of kidney disease. Recently developments in 
new molecular genetic techniques have presented visions in the role of genetic change in kidney disorders 
with the possibility of developing the path of kidney disease and benefit from precautionary treatment [2]. 
Genetic factors can affect the phenotype of the renal disease in several ways: the vulnerability to renal disease, 
the normal course of the disease, and the treatment reaction.  To order to understand the role of genetic factors 
to renal disorder, it is important to recognize between these possible mechanisms [3]. Angiotensin-converting 
enzyme (ACE) genotype is perhaps one of the risk factors for both the progression and advancement of renal 
disorders or may indicate genetic propensity to illness [3]. The human ACE quality is situated on chromosome 
17 (17q23) contains 25 introns and 26 exons [3, 4]. ACE gene has in excess of 160 gene polymorphisms; 
Single nucleotide polymorphism (SNP) is the vast majority.  In this gene, the SNP includes either a deletion 
(D) allele or an insertion (I) allele in a DNA sequence of 287-basepair in intron 16 of the ACE gene coding 
structuring three probable genotypes: DD, II or ID [4] ( Zhou et al.,2012). Many studies were carried out to 
determine the association between ACE polymorphism and renal failure progression [4-6]. 
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 The results of one studies conducted on Lebanese individuals indicated that allele D can be considered a 
factor eligible for progression of both DN and DN to ESRD in Lebanese who suffer from T2DM [7].  Also, in 
Iran Rahimi et al [8] indicated that ACE D allele increases the risk of hypertension in ESRD patients. [8] 
 Recently, the results of Al-Radeef et al. in Baghdad, showed that the angiotensin-converting enzyme genetic 
polymorphism had a significant impact on serum erythropoietin rates and had no significant effect on 
hemoglobin levels in Iraqi hemodialysis patients [9]. 
 Thus, the D allele is reported to be either indifferent, or associated with the worst renal diagnosis, the 
evidence seems to favor the role of the allele in the development of renal function loss, although not in the 
entire population and not at all. 
 Therefore, this study was designed to be one of the studies that highlight chronic renal failure in Thi Qar 
province, by studying the genetic profile of one gene associated with genetic predisposition to the 
development of renal failure by evaluating the role of ACE I/D SNP polymorphism for patients with healthy 
people and renal failure as a diagnostic sign of early disease detection. 
1.2. Material and methods 
This study was conducted at Immunological and Molecular Laboratory University of Thi-Qar-college of 
science in pathological analysis department, on a group of patients at AL-Hussein Teaǁching Hospital iǁn Tǁhi-
Qǁar, and the control group at the period between October 2018 to May 2019. It included (120 subjects (50 
control range of age from 25-60 and 70 patients with chronic renal failure ranged from 25-70). Patients 
(before the dialysis session) collected three milliliters of venous blood samples and were healthy. Serums have 
been isolated from two ml of centrifuged blood samples and the specific serum is used to test biochemical 
parameters (creatinine and urea), while the remaining one ml has been stored in EDTA vials of genomic DNA 
extraction. According to the Promega protocol of the manufacturer, genomic DNA extracted from blood 
samples using the RediaperTM Blood gDNA Miniprep System (Promega, USA) provides a quick, simple 
technique for mammalian blood preparation of purified and intact DNA, the quality and concentration of 
extracted DNA were analyzed by using Nano drop spectrophotometer 1000 – Taiwan that assessed  the 
consecration  at (ng/μl) and evaluated the quality (purity)  of DNA  by reading the absorbance at (260/280 nm) 
and the DNA bands have been seen by electrophoresis of the agarose gel. 
 The polymorphism of the ACE gene was detected using polymerase chain reaction (PCR) using the 
technique defined by Al-Radeef et al. [9]. The SNP in ACE gene involves two allelic forms (D and I), 
corresponding to the deletion or the insertion that forms three probable genotypes: DD, II or ID.  
 The ACE gene coding sequence has been enhanced from genomic DNA using sequence specific 
oligonucleotide primers: 
Forward: 5ǁ’C ǁTǁGǁ ǁGǁAǁG ǁAǁCǁCǁ ǁAǁCǁT ǁCǁCǁC ǁAǁTC CTTTCT ǁ3ǁ’ 
Reverse: ǁ5ǁ’ GǁAǁT GǁTǁG ǁGǁCǁC AǁTǁC AǁCǁAǁ TǁTǁC GTCAGA T3’. 
The reaction mix and PCR conditions are given in (Table1) and (Table 2). 
The samples were subjected to electrophoresis of 1.5 % agarose gel electrophoresis at 72 V for 60 min and 
visualized at room temperature under UV light after Nancy DNA-520 (Sigma-UK) staining (10μL/50mL) to 
characteristic fragment patterns of ACE gene locus PCR products (490 bp for insertion and 190 bp for 
deletion products). 
 Statistical calculations were made using version 22 of the SPSS program. For each variable the values 
are presented as mean± SD; in all measurements, p value 0.05 has been considered statistically significant. 
Odds ratio and relative risk were used to quantify the strength of the connotation between genotypes alleles of 
angiotensin-converting enzyme gene and the risk of development CRF in Iraqi patients. 
1.3. Results 
Table (3) showed a significant decrease in the serum urea and creatinine level in the group of patients 
compared to the control group (p≤0.05). This results agree with previous studies [10, 11]. Reduced number of 
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nephrons in the renal failure increases the level of urea and creatinine that occurs because the kidneys lose 
their ability to get rid of nitrogenous waste from the blood leading to the accumulation of these substances in 
the blood [12, 13]. 
Angiotensin-Converting Enzyme polymorphism:   
 The present study is the first study, investigating associate between ACE polymorphism genotypes 
and CRF in Iraqi patients of Thi-Qar as far as we know. 
Evaluate the concentration and purity of Extracted DNA:   
 Genomic DNA in this study, has been isolated from patients' blood and healthy control groups, all 
samples yielded intact genomic DNA as shown in (Figure 1). The results of DNA isolation showed that there 
are 60 samples of good quality and absorption when measured by nano spectrometry (Nanodrob).  The 
concentration of DNA ranged from ( 21.3 -118.1 ng/µl ) with mean of  50.8 ng/µl  , the purity of  DNA  
ranged from (1.65-1.9) with a mean of 1.77 as  indicated in (Figure 2 ), DNA concentration and purity higher 
than that of human genomic DNA isolated by [14] , the  results demonstrate the efficiency of  the methods and 
material that provided by bromega extraction kit  comparing to  extraction method or other Kit  that  used by 
[7]  . 
Table 1. The PCR reaction mix (25 µl) for ACE gene 
Chemicals Volumes 
DNA 5 ml 
Hot start master mix 7.5 
Primer forward 1 
Primer reverse 1 
Nuclease free water 5.5 
Total volume 20 
 
 
Table 2. PCR conditions for angiotensin-converting enzyme gene 
Steps Temperature Time No. of cycles 
Denaturation 1 95 3 min 1 
Denaturation 2 95 30 sec. 
35 Annealing 58 30 sec. 
Extension 1 72 30 sec. 
Extension 2 72 5 min 1 
 
Table 3.  Levels of renal function tests in control and patients groups 
 
Parameters  
 
Control 
(Mean ±SD) 
Patient 
(Mean ±SD) 
Lsd 
  50    70  
Urea( mg/dl) 29.12±6.21 
b
 71.82±15.01 
a 
3.22 
Creatinine( mg/dl) 1.02±0.23 
b
 5.33±1.03 
a
 0.20 
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Figure 1. Purity of genomic DNA bands of 40 samples at 0.8% agarose gel at 80 voltages 
 
 
Figure 2. The quality and concentration of genomic DNA 
 
 
Figure 3. ACE gene I/D polymorphisms on 1.5% agarose gel at 72 voltage for one hour. 1, M: DNA ladder 
(100 bp), Individuals were homozygous for the D allele (DD; 190 bp lane 1, 2,3,8,14,17, and 18-20). 
Individuals were homozygous for the allele (II genotypes; 490 bp, lane 5, and 10). Heterozygous individuals 
for the ID genotype (190 bp, and 490 bp, lane 4, 6, 7, 9, 11-13, 15, and 16). The distribution of ACE 
polymorphisms by genotype and allele frequencies are presented in (Table 4) and (Table 5). 
 
After that the DNA samples used to prepare PCR product for ACE gene. The results of the PCR analysis 
presented that the presence of a single 190 bp PCR material established the homozygous individuals for the 
deletion allele D (DD genotype). Then, The presence of a single 490 bp PCR product was described as 
homozygous for I allele (II genotype), while the existence of 190 and 490 bp PCR products were reported as 
heterozygous individuals (ID genotype) as shown in (Figure 3).  
 
Minimum 
Maximum 
Mean 
21.3 
118.1 
50.8 1.65 1.9 
1.77 
Consetration ng/µl     Purity 260/280 
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Table 4. Genotypes distribution of ACE polymorphism among patients and healthy control 
S: Significant, HS: High significant, NS: Non significant 
 
ACE Control 
NO.16 
CKD 
NO.44 
P value Odds 
Ratio 
Relative 
Risk for 
control  
Relative 
Risk for 
patient 
DD 6 /16 (37.5%) 23/44(52.3%) 0.002
HS 
1.825 0.764 1.394 
II 4/16 (25%) 5/44(11.4%) 0.033
S
 0.385 1.182  0.455 
ID 6/16(37.5%) 16/44(36.3%) 0.793
NS 
0.952 1.018 0.970 
Total 16/60(26.7%) 44/60(73.3%) ….. …… …… …… 
p-value 
X
2 
P>0.05NS 
3.34 
1.01 HS 
10.38 
    
 
Table 5. Alleles frequencies of ACE polymorphisms in CRF patients and healthy control 
ACE allele 
frequency 
Deletion No. (%) Insertion No. (%) Total No. (%) 
CRF patients  62(70. 5%) 26(29.5%) 88(100%) 
Healthy  20(62.5%) 12(37.5%) 32(100%) 
Cal.X
2
: 0.686 , df:1  ,Tab.X
2
: 6.63, P.value ≤0.05, Odds ratio:1.43 
1.4. Discussion 
 Comparison of ACE genotype frequencies in patients with CRF and healthy showed that the DD 
genotype percentage has been discovered to be high in group 23 (52.3 %) of patients; subsequently ID 
16(36.3%) and II genotype 5(11.4%) (Table 4). While, the genetic pattern in the control group showed that the 
genotype DD and ID patterns had the same percentage of 37.3%, followed by genotype II, 25%. Table (5) 
shows that, by comparing with healthy controls, there may be an increase in D-allele frequencies in the group 
of patients. 
 However, there are significant differences between control groups and patients   in II genotypes and the 
frequency of DD, but there are no significant statistical differences between them in the genotype of SNP 
ACE genotypes. These results are in accordance with a few studies, such as the Sabbar's et al [6] study in Iraq, 
that showed that the DD genotype percentages were identified to be 56 % high in the group of patients, led by 
ID 28 percent and II genotype 16 percent. They also indicated significant differences in DD (P value was 
0.0019 and odd ratio 2.47) between patients and control group, whereas II genotype (P value 0.02 and odd 
ratio 0.44) did not show a significant difference in the ID genotype (P value > 0.05), according to the results 
of Ali et al. [14] who stated that the D allele repetition in ESRD patients was higher (42.40%) than in healthy 
control patients in Malaysia (31.05%). Rahimi et al [8], in Iran discovered that the frequencies of ACE 
genotypes and allles were not statistically different compared to ESRD patients and controls; the latest 
findings are inconsistent with the current study showing that there is a significant statistical difference 
between patients and the control group in SNP ACE genotypes (DD and II). 
 The current study did not match the results of another local study in Baghdad by Al-Radeef et al. [9] 
showed that most frequent ID genotype followed by DD and II in overall CKD events, with no significant 
difference between chronic kidney disease and healthy subjects in these genotypes [9] . 
 This mismatch can be due to a very important reason related by the small size of the studied samples, 
environmental heterogeneity and natural genetic in different ethnic groups or it might as the result of the 
method that is used in this study. From the current results described above, we found that the ACE genotype 
of the form (DD) and, (D) allele was associated with a relative risk (1.394) and odd ratio (1.825) of CRF. 
Moreover, most of the studies we cited showed that DD allele was mostly associated with patient progression 
to ESRD despite the percentage of allele frequency.  
1.5. Conclusions 
The high frequency of ACE DD genotype and D allele compared to control in CRF patients can be a 
significant factor in the development of renal failure. 
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